Treatment of AML by inhibitors of NHR2 and/or RUNX1/ETO-tetramerization provides a therapy option with a unique mode of action.
[Detail]
A new way of designing and constructing surfaces is a layer of gas even under changing pressure conditions. Structured, non-wettable surfaces are used for various applications. The surfaces of the lattice structures are liquid-repellent and in particular hydrophobic as well as oleophobic.
[Detail]
A proliferation marker to visualise cell cycle progression in vitro and in vivo with high spatial resolution of the M-phase
[Detail]
Monoclonal antibodies for research, which are specific for CEACAM1. In contrast to available antibodies the two antibodies exhibit a high affinity and specificity for the A1/B-domains of human CEACAM1 and do not bind to other members of the family of CEACAM-family.
[Detail]
Covalent-allosteric AKT inhibitors: high affinity inhibitors with A new mode of binding for cancer therapy.
[Detail]
| |< <- | [9] [10] [11] [12] [13] [14] [15] [16] [17] [18] [19] | -> >| |
